Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: Comparison with estradiol-17β

European Journal of Endocrinology

Volumn 149, Issue 4, 2003, Pages 351-362

  Seidlová Wuttke, Dana ^b   Hesse, Oda ^b   Jarry, Hubertus ^b   Christoffel, Volker ^a   Spengler, Barbara ^a   Becker, Tamara ^b   Wuttke, Wolfgang ^b  

^a Bionorica AG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CIMICIFUGA RACEMOSA EXTRACT; COLLAGEN TYPE 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR BETA; LUTEINIZING HORMONE; OSTEOCALCIN; OSTEOPROTEGERIN; PROGESTERONE RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG MECHANISM; EVIDENCE BASED MEDICINE; FEMALE; GENE EXPRESSION; HORMONE INHIBITION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; METAPHYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TIBIA; UTERUS; UTERUS WEIGHT;

ACID PHOSPHATASE; ANIMALS; BONE DENSITY; CIMICIFUGA; COLLAGEN TYPE I; COMPLEMENT C3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FEMUR; GENE EXPRESSION; GLYCOPROTEINS; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; ORGAN SIZE; OSTEOCALCIN; OSTEOPROTEGERIN; OVARIECTOMY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; UTERUS;

EID: 0142216493     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490351     Document Type: Article

References (47)

1. Couse JF & Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Reviews 1999 20 358-417.
2. Düker E-M, Kopanski L, Jarry H & Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Medica 1991 57 420-424.
3. Cosman F & Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocrine Reviews 1999 20 418-434.
4. Knobil E. Neuroendocrine control of the menstrual cycle. Recent Proceedings in Hormone Research 1980 36 53-88.
5. Tataryn IV, Meldrum DR, Lu KH, Frumar AM & Judd HL. LH, FSH and skin temperature during the menopausal hot flash. Journal of Clinical Endocrinology and Metabolism 1979 49 152-154.
6. Weihua Z, Saji S, Mäikinen S, Cheng G, Jensen EV, Warner M et al. Estrogen receptor (ER) β, a modulator of ERα in the uterus. PNAS 2000 97 5936-5941.
7. Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J et al. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. Journal of Biological Chemistry 2002 277 8531-8537.
8. 2 progression in the estradiol-induced mitotic cycle. PNAS 1999 96 3287-3291.
9. Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G & Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. Journal of Steroid Biochemistry and Molecular Biology 2000 73 1-10.
10. Onoe Y, Miyaura C, Ohta H, Nozawa S & Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology 1997 138 4509-4512.
11. Windahl SH, Norgard M, Kuiper GG, Gustafsson JA & Andersson G. Cellular distribution of estrogen receptor beta in neonatal rat bone. Bone 2000 26 117-121.
12. Lim SK, Won YJ, Lee HC, Huh KB & Park YS. A PCR analysis of ERα mRNA abundance in rats and the effect of ovariectomy. Journal of Bone and Mineral Research 1999 14 1189-1196.
13. Waters KM, Rickard DJ, Riggs BL, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS et al. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. Journal of Cell Biochemistry 2001 83 448-462.
14. Collier FM, Huang WH, Holloway WR, Hodge JM, Gillespie MT, Daniels LL et al. Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology 1998 139 1258-1267.
15. Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C & Andersson G. Female estrogen receptor β - / -mice are partially protected against age-related trabecular bone loss. Journal of Bone and Mineral Research 2001 16 1388-1398.
16. Windahl SH, Vidal O, Andersson G, Gustafsson JA & Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ - / -mice. Journal of Clinical Investigation 1999 104 895-901.
17. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997 89 309-319.
18. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. PNAS 1999 96 3540-3545.
19. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998 93 165-176.
20. Hotbauer LC & Heufelder AE. Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. European Journal of Endocrinology 1998 139 152-154.
21. Danielsen CC & Flyvbjerg A. Insulin-like growth factor 1 as a predictor of cortical bone mass in a long term study of ovariectomized and estrogen-treated rats. Bone 1996 19 493-498.
22. Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J et al. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats. Journal of Bone and Mineral Research 1996 11 1723-1735.
23. Shinoda M, Latour MG & Lavoie JM. Effects of physical training on body composition and organ weights in ovariectomized and hyperestrogenic rats. International Journal of Obesity Related Metabolic Disorders 2002 26 335-343.
24. Helterbrand JD, Higgs RE Jr, Iversen PW, Tysarczyk-Niemeyer G & Sato M. Application of automatic image segmentation to tibiae and vertebrae from ovariectomized rats. Bone 1997 21 401-409.
25. Heid CA, Stevens J, Livak KJ & Williams PM. Real time quantitative PCR. Genome Research 1996 6 986-994.
26. Spereafico E, Bettini E, Pollio G & Maggi A. Nucleotide sequence of estrogen receptor cDNA from Sprague-Dawley rat. European Journal of Pharmacology 1992 227 353-356.
27. Kuiper GG, Emnark E, Pelto-Huikko M, Nilsson S & Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. PNAS 1996 93 5925-5930.
28. Park-Sarge OK & Mayo KE. Regulation of the progesterone receptor gene by gonadotropins and cyclic adenosin3′,5′-monophosphate in rat granulosa cells. Endocrinology 1994 134 709-718.
29. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. PNAS 1990 87 2628-2632.
30. Misumi Y, Sohda M & Ikehara Y. Nucleotide and deduced amino acid sequence of rat complement C3. Nucleic Acids Research 1990 18 2178.
31. Brandsten C, Lundmark C, Christersson C, Hammarstrom L & Wurtz T. Expression of collagen alphal(I) mRNA variants during tooth and bone formation in the rat. Journal of Dental Research 1999 78 11-19.
32. Pan LC & Price PA. The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. PNAS 1985 82 6109-6113.
33. Ek-Rylander B, Bill P, Norgaad M, Nilsson S & Andersson G. Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone. Journal of Biological Chemistry 1991 266 24684-24689.
34. Jarry H, Gorkow CH & Wuttke W. Treatment of menopausal symptoms with extracts of Cirnicifuga racemosa: in vivo and in vitro evidence for estrogenic activity. In Phytopharmaka in Forschung und klinischer Anwendung, pp 99-112. Eds D Loew & N Rietbrock. Darmstadt: Steinkopff, 1995.
35. Cullinan-Bove K & Koos RD. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 1993 13 829-837.
36. Mäkelä S, Savolainen H, Aavik E, Myllärniemi M, Strauss L, Taskinen E et al. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β. PNAS 1999 96 7077-7082.
37. Gruber R, Czerwenka K, Wolf F, Ho G-M, Willheim M & Peterlik M. Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor α- and β-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells. Bone 1999 24 465-473.
38. Lindberg MK, Alatalo SL, Halleen JM, Mohan S, Gustafsson JA & Ohlsson C. Estrogen receptor specificity in the regulation of the skeleton in female mice. Journal of Endocrinology 2001 171 229-236.
39. Wakisaka A, Tanaka H, Barnes J & Liang CT. Effect of locally infused IGF-I on femoral gene expression and bone turnover activity in old rats. Journal of Bone and Mineral Research 1998 13 13-19.
40. Bikle DD, Harris J, Halloran BP, Roberts CT, Leroith D & Morey-Holton E. Expression of the genes for insulin-like growth factors and their receptors in bone during skeletal growth. American Journal of Physiology 1994 267 E278-E286.
41. Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA & Riggs BL. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcified Tissue International 1998 62 60-66.
42. Wronski TJ, Contrón M & Dann LM. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcified Tissue International 1988 43 179-183.
43. Turner RT, Vandersteenhoven JJ & Bell NH. The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats. Journal of Bone and Mineral Research 1987 2 115-122.
44. Jarry H & Harnischfeger G. Studies on the endocrine effects of the contents of Cirnicifuga racemosa: 1. Influence on the serum concentration of pituitary hormones in ovariectomized rats. Planta Medica 1985 51 46-49.
45. Struck D, Tegtmeier M & Harnischfeger G. Flavones in extracts of Cimicifuga racemosa. Planta Medica 1997 63 289.
46. Kruse SO, Lochning A, Pauli GF, Winterhoff H & Nahrstedt A. Fukinic and piscidic acid esters from the rhizome of Cirnicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Medica 1999 65 763-764.
47. Wuttke W, Seidlová-Wuttke D, Gorkow C & März R. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens and placebo in a double-blind placebo controlled study: effects on menopause symptoms and bone markers. Maturitas 2003 44 67-77.